Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study-Reference-Cited by-同舟云学术

Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study

Published:2006-02-27 Issue:7 Volume:37 Page:651-659
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Gonçalves A,Delva R,Fabbro M,Gladieff L,Lotz J-P,Ferrero J-M,Linassier C,Cottu P-H,Viens P,Extra J-M

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1705302.pdf

Reference47 articles.

1. Conte PF, Cianci C, Gadducci A . Up date in the management of advanced ovarian carcinoma. Crit Rev Oncol Hematol 1999; 32: 49–58.

2. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996; 334: 1–6.

3. Piccart MJ, Bertelsen K, James K, Cassidy J, Mangioni C, Simonsen E et al. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst 2000; 92: 699–708.

4. Levin L, Hryniuk WM . Dose intensity analysis of chemotherapy regimens in ovarian carcinoma. J Clin Oncol 1987; 5: 756–767.

5. Jodrell DI, Egorin MJ, Canetta RM, Langenberg P, Goldbloom EP, Burroughs JN et al. Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. J Clin Oncol 1992; 10: 520–528.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are there candidates for high-dose chemotherapy in ovarian carcinoma?;Journal of Experimental & Clinical Cancer Research;2012-10-16

2. Solid tumors in adults;Hematopoietic Stem Cell Transplantation in Clinical Practice;2009

3. Phase III Trial of High-Dose Sequential Chemotherapy With Peripheral Blood Stem Cell Support Compared With Standard Dose Chemotherapy for First-Line Treatment of Advanced Ovarian Cancer: Intergroup Trial of the AGO-Ovar/AIO and EBMT;Journal of Clinical Oncology;2007-09-20

4. Hochdosischemotherapie beim fortgeschrittenen Ovarialkarzinom;Der Onkologe;2007-06